APLT

Applied Therapeutics (APLT)

About Applied Therapeutics (APLT)

Applied Therapeutics, Inc. is a clinical-stage biopharmaceutical company which engages in the development of a pipeline of novel products. It is targeting treatments for central nervous system rare diseases and diabetic complications. The company was founded by Shoshana Shendelman on January 20, 2016 and is headquartered in New York, NY.

Details

Daily high
$0.12
Daily low
$0.10
Price at open
$0.11
52 Week High
$1.50
52 Week Low
$0.10
Market cap
16.9M
Dividend yield
0.00%
Volume
15.0M
Avg. volume
26.8M
P/E ratio
-1.17

Applied Therapeutics News

Details

Daily high
$0.12
Daily low
$0.10
Price at open
$0.11
52 Week High
$1.50
52 Week Low
$0.10
Market cap
16.9M
Dividend yield
0.00%
Volume
15.0M
Avg. volume
26.8M
P/E ratio
-1.17